MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析

◆英語タイトル:MEI Pharma Inc (MEIP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61270FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MEI Pharma Inc (MEIP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MEI Pharma Inc (MEI Pharma), formerly Marshall Edwards Inc, develops drugs for the treatment of cancer. The company’s drug candidates include pracinostat, an oral histone deacetylase inhibitor, intended for the treatment of advanced hematological diseases including myelodysplastic syndrome; ME-344, a mitochondrial inhibitor intended for the treatment of HER2-negative breast cancer and solid tumors; and Zandelisib (ME-401), an oral PI3K delta inhibitor for relapsed or refractory B-cell malignancies. The company also develops and commercializes Voruciclib, an oral and selective cyclin-dependent kinase (CDK) inhibitor intented for the treatment of acute myeloid leukemia (AML) and B-cell malignancies through an agreement with Presage. MEI Pharma is headquartered in San Diego, California, the US.

MEI Pharma Inc Key Recent Developments

Apr 05,2021: MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference
Feb 04,2021: MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights
Nov 10,2020: MEI Pharma reports first quarter fiscal year 2021 results and operational highlights
Sep 09,2020: MEI Pharma reports fiscal year 2020 results and operational highlights
May 07,2020: MEI Pharma reports fiscal third-quarter 2020 results and recent corporate highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MEI Pharma Inc – Key Facts
MEI Pharma Inc – Key Employees
MEI Pharma Inc – Key Employee Biographies
MEI Pharma Inc – Major Products and Services
MEI Pharma Inc – History
MEI Pharma Inc – Company Statement
MEI Pharma Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
MEI Pharma Inc – Business Description
R&D Overview
MEI Pharma Inc – Corporate Strategy
MEI Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
MEI Pharma Inc – Strengths
MEI Pharma Inc – Weaknesses
MEI Pharma Inc – Opportunities
MEI Pharma Inc – Threats
MEI Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MEI Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 05, 2021: MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference
Feb 04, 2021: MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights
Nov 10, 2020: MEI Pharma reports first quarter fiscal year 2021 results and operational highlights
Sep 09, 2020: MEI Pharma reports fiscal year 2020 results and operational highlights
May 07, 2020: MEI Pharma reports fiscal third-quarter 2020 results and recent corporate highlights
Apr 14, 2020: MEI Pharma appoints Cheryl Cohen, product launch and commercialization veteran, to its board of directors
Feb 06, 2020: MEI Pharma reports fiscal second-quarter 2020 results and operational highlights
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MEI Pharma Inc, Key Facts
MEI Pharma Inc, Key Employees
MEI Pharma Inc, Key Employee Biographies
MEI Pharma Inc, Major Products and Services
MEI Pharma Inc, History
MEI Pharma Inc, Key Competitors
MEI Pharma Inc, Ratios based on current share price
MEI Pharma Inc, Annual Ratios
MEI Pharma Inc, Annual Ratios (Cont...1)
MEI Pharma Inc, Interim Ratios
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MEI Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jordan Ahli Bank PSC:企業の戦略・SWOT・財務分析
    Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report Summary Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oxford Performance Materials Inc-医療機器分野:企業M&A・提携分析
    Summary Oxford Performance Materials Inc (OPMI), a subsidiary of Arkema Inc is a chemical company that manufactures thermoplastic polymers. The company’s products include proprietary polyether ketone ketone formulations, additives, complex assemblies, biomedical raw materials, biomedical parts, robo …
  • TPI Composites Inc (TPIC):電力:M&Aディール及び事業提携情報
    Summary TPI Composites Inc (TPI) is a provider of wind energy products and composite materials. The company designs and manufactures composite wind blades and provides single source solutions to the global wind turbine manufacturers. The company also provides precision molding and assembly systems u …
  • Glow Energy Public Co Ltd:発電所・企業SWOT分析
    Glow Energy Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Atlas Genetics Ltd-医療機器分野:企業M&A・提携分析
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • Sunflower Electric Power Corporation:企業の戦略的SWOT分析
    Sunflower Electric Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • IRB Infrastructure Developers Ltd:企業の戦略・SWOT・財務情報
    IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report Summary IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • IntelGenx Corp:企業のM&A・事業提携・投資動向
    IntelGenx Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IntelGenx Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Tech Mahindra Limited:企業の戦略・SWOT・財務分析
    Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bakkavor Group Limited:企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure life-threatening diseases. The company's pipeline products include SLN124, SLN500 and SLN360. Its SLN124 is developed for the treatment of cardiovascula …
  • TRC Companies Inc:電力:M&Aディール及び事業提携情報
    Summary TRC Companies Inc (TRC Companies) is a construction service provider that offers engineering, consulting and construction management. The company’s services include air quality management, power generation, power delivery engineering, integrity management, energy efficiency, coal ash managem …
  • Taylor Morrison Home Corp:企業の戦略・SWOT・財務分析
    Taylor Morrison Home Corp - Strategy, SWOT and Corporate Finance Report Summary Taylor Morrison Home Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Leaf Clean Energy Company (LEAF):企業の財務・戦略的SWOT分析
    Summary Leaf Clean Energy Company (Leaf Clean Energy) is a provider of renewable energy and sustainable technology investments. It offers growth and venture capital across the renewable energy industry to support novelty, well-managed and rapidly-growing companies. It operates and manages energy pro …
  • Alternative Networks Plc:戦略・SWOT・企業財務分析
    Alternative Networks Plc - Strategy, SWOT and Corporate Finance Report Summary Alternative Networks Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CytoSorbents Corp (CTSO):医療機器:M&Aディール及び事業提携情報
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriou …
  • Qiagen NV (QIA):医療機器:M&Aディール及び事業提携情報
    Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company offers consumable products, instruments and automation systems. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify …
  • China Datang Corp:電力:M&Aディール及び事業提携情報
    Summary China Datang Corp (CDT) is engaged in development, investment, construction, operation and management of power generation assets. The company provides electric power equipment, environment protection device, memory card and card reader; religion crafts, meter for electricity, safety products …
  • BioStar Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • GRI Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary GRI Bio Inc (GRI Bio) is a biotech company that develops and manufactures therapies for inflammatory diseases. The company develops Natural Killer T cell based therapies for the treatment of liver disease and autoimmune disoders. Its lead candidate GRI-0621, a novel oral therapeutic for live …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆